NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered peptides from HK Peptides? Mail in a sample (US only) and let us test it.

Test my supply
+5 more ↓
73%
Finnrick rating
#257 of 500 ranked vendors
364 of 469 classifiable tests passed
methodology · Purity focus
Finnrick analysis

HK Peptides' broad, recent purity-focus record is strongest in Retatrutide and GHK-Cu, where many passing lots are tempered by identity or fill outliers. Tesamorelin and CJC-1295 are much more dispersed, with repeated purity misses, large quantity errors, and limited batch identifiers despite some later rebounds.

methodology →
vendor intelligence report
Vendor Intelligence Report: HK Peptides

Corporate records tie the storefront’s history to a mainland entity now shown as deregistered, while the live HK Peptide Ltd counterparty remains unresolved. The report maps lookalikes, copied web text, WHOIS trails, payment rails, and an anti-scam phone contradiction.

38 pages5 risk factors assessed12 Nov 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.07
87%
52
2
Retatrutide
$1.00
86%
146
3
Tirzepatide
$0.40
83%
136
4
PT-141
-
73%
7
5
BPC-157
$0.82
73%
23
6
Melanotan II
$0.41
68%
12
7
Semaglutide
$0.70
62%
12
8
Cagrilintide
$2.30
59%
11
9
Ipamorelin
$0.81
55%
14
10
Tesamorelin
$1.78
48%
34
11
Sermorelin
$1.57
45%
6
12
TB-500
$1.76
44%
10
13
CJC-1295
$1.90
29%
10
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%20 Jul 2026: 74%3 Aug 2026: 74%3 Aug 2026: 74%3 Aug 2026: 74%3 Aug 2026: 74%9 Aug 2026: 74%12 Aug 2026: 74%13 Aug 2026: 74%26 Aug 2026: 74%28 Aug 2026: 74%28 Aug 2026: 74%28 Aug 2026: 74%28 Aug 2026: 74%28 Aug 2026: 73%4 Sep 2026: 73%9 Sep 2026: 73%9 Sep 2026: 73%9 Sep 2026: 73%10 Sep 2026: 73%14 Sep 2026: 73%15 Sep 2026: 73%17 Sep 2026: 73%24 Sep 2026: 73%24 Sep 2026: 73%24 Sep 2026: 73%24 Sep 2026: 73%24 Sep 2026: 73%24 Sep 2026: 73%30 Sep 2026: 73%3 Oct 2026: 73%5 Oct 2026: 73%5 Oct 2026: 73%6 Oct 2026: 73%6 Oct 2026: 73%12 Oct 2026: 73%20 Oct 2026: 73%20 Oct 2026: 73%2 Nov 2026: 73%2 Nov 2026: 73%10 Nov 2026: 73%17 Nov 2026: current 73%74%73%73%Jul 26Nov 26
Peptide testing

Ordered peptides from HK Peptides? Mail in a sample (US only) and let us test it.

Test my supply
HK Peptides test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
10 Nov 2026
Pass
Semaglutide
lab nameView COA
2 Nov 2026
Pass
Retatrutide
lab nameView COA
2 Nov 2026
Fail
BPC-157
lab nameView COA
20 Oct 2026
Pass
Tirzepatide
lab nameView COA
20 Oct 2026
Pass
Retatrutide
lab nameView COA
12 Oct 2026
Pass
GHK-Cu
lab nameView COA
6 Oct 2026
Pass
Tirzepatide
lab nameView COA
6 Oct 2026
Pass
GHK-Cu
lab nameView COA
5 Oct 2026
Fail
Semaglutide
lab nameView COA
5 Oct 2026
Pass
Tirzepatide
lab nameView COA
1-10 of 200

About HK Peptides test results from Finnrick

HK Peptides is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 13 peptides and 473 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible HK Peptides peptides in this dataset are BPC-157 (23 tests) and Melanotan II (12 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 200 recent tests.

Corrections
No corrections.
Peptide testing

Ordered peptides from HK Peptides? Mail in a sample (US only) and let us test it.

Test my supply